References
- Stoller R. G., Hande K. R., Jacobs S. A., Rosenberg S. A., Chabner B. A. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. N. Engl. J. Med. 1977; 297: 630
- VonHoff D. D., Penta J. S., Helman L. J., Slavik M. Incidence of drug‐related deaths secondary to high dose methotrexate and citrovorin factor administration. Cancer Treat. Rep. 1977; 61: 745
- Hande K. R., Balow J. E., Drake J. C., Rosenberg S. A., Chabner B. A. Methotrexate and hemodialysis. Ann. Intern. Med. 1977; 87: 496
- Benjamin R. S., Riggs C. E., Bachur N. R. Pharmacokinetics and metabolism of adriamycin in man. Clin. Pharmacol. Ther. 1973; 14: 592
- Lefrak E. A., Pitha J., Rosenbein S., Gottlieb J. A. A clini‐copathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32: 303
- Benjamin R. S., Wiernik P. H., Bachur N. R. Adriamycin chemotherapy efficacy safety pharmacologic basis of an intermittent high dosage schedule. Cancer 1974; 33: 19
- Winchester J. F., Tilstone W. J., Edwards R. O., Gilchrist T., Kennedy A. C. Hemoperfusion for enhanced drug elimina‐tion‐A kinetic analysis in paracetamol poisoning. Trans. Am. Soc. Artif. Intern. Organs 1974; 20: 358
- Winchester J. F., Gelfand M. C., Tilstone W. J. Hemoperfusion in drug intoxication‐Clinical and laboratory aspects. Drug Metab. Rev. 1978; 8: 69
- Tilstone W. J., Reavey P. C., Winchester J. F. The use of pharmacokinetic principles in determining the effectiveness of removal of toxins from blood. Clin. Pharmacokinet. 1979; 4: 23
- Gibson T. P., Lucas S. V., Nelson H. A., Atkinson A. J., Okita G. T., Ivanovich P. Hemoperfusion removal of digoxin from dogs. J. Lab. Clin. Med. 1978; 91: 673
- Metzler C. M. NONLIN‐A Computer Program for Parameter Estimation in Non‐Linear Situations (Technical Report No. 7292/69/7292/005). Upjohn Co., Kalamazoo, Michigan November 25, 1969
- Huffman D. H., Benjamin R. S., Bachur N. R. Daunorubicin metabolism in acute non‐lymphocytic leukemia. Clin. Pharma‐col. Ther. 1972; 13: 895
- Schreiner G. E. Dialysis of poisons and drugs‐Annual review. Trans. Am. Soc. Artif. Intern. Organs 1970; 16: 544
- Gwilt P. R., Perrier D. Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyz‐ability. Clin. Pharmacol. Ther. 1978; 24: 154
- Takki S., Gambertoglio J. G., Honda D. H., Tozer T. N. Pharmacokinetic evaluation of hemodialysis in acute drug overdose. J. Pharmacokinet. Biopharm. 1978; 6: 427
- Gibson T. P., Atkinson A. J. Effect of changes in intercom‐partment rate constants on drug removal during hemoperfusion. J. Pharm. Sci. 1978; 67: 1178
- Gibson T. P., Reich S. D., Krumlovsky F. A., Ivanovich P., Gonczy C. Hemoperfusion for methotrexate removal. Clin. Pharmacol. Ther. 1978; 23: 351
- Davidson W. D., Isacoff W. H., Block J. B. Methotrexate “escape” using charcoal hemoperfusion: An alternative to citro‐vorum rescue. Trans. Am. Soc. Artif. Intern. Organs 1977; 6: 16, (Abstract’
- Isacoff W. H., Davidson W. D., Block J. B. Effects of extra corporeal charcoal hemoperfusion on plasma methotrexate. Am. Assoc. Cancer Res. 1977; 145, (Abstract)
- Djerassi L., Cresselka W., Kim J. S. Removal of methotrexate by filtration adsorption using charcoal filters or by hemodialysis. Cancer Treat. Rep. 1977; 61: 751
- Howell S. B., Blair H. E., Uren J., Frei E. Hemodialysis and enzymatic cleavage of methotrexate in man. Eur. J. Cancer 1978; 14: 787
- lVinchester J. T.T., Rahman A., Tilstone W. J., Kessler A., Mortensen L., Schreiner G. E., Schein P. S. Sorbent removal of adriamycin in vitro and in vivo. Cancer Treat. Rep. 1979; 63: 1787
- Rahman A., Winchester J. F., Bregman H., Mortensen L. M., Schreiner G. E., Schein P. S. Methotrexate adsorption during charcoal hemoperfusion: In vivo and in vitro observations, In preparation